Stock comparison
Medtronic plc is 47.0x more valuable than Axogen, Inc. by market capitalization ($120.54 B vs $2.57 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDT is larger
Medtronic plc is 47.0x more valuable than Axogen, Inc. by market capitalization ($120.54 B vs $2.57 B).
Market value leader
MDT
Medtronic plc is 47.0x more valuable than Axogen, Inc. by market capitalization ($120.54 B vs $2.57 B).
Revenue leader
MDT
AXGN: $225.21M vs MDT: $36.36B.
Profit leader
MDT
AXGN: -$15.70M vs MDT: $4.80B.
Margin leader
MDT
AXGN: -7.0% vs MDT: 13.2% net margin.
| Metric | AXGN | MDT |
|---|---|---|
| Market cap | $2.57 B | $120.54 B |
| US-listed rank | #1970 | #130 |
| Revenue (latest FY) | $225.21M | $36.36B |
| Net income (latest FY) | -$15.70M | $4.80B |
| Net margin | -7.0% | 13.2% |
| P/E (trailing FY) | - | 25.1x |
| SEC filings | 1,334 | 1,000 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medtronic plc is 47.0x more valuable than Axogen, Inc. by market capitalization ($120.54 B vs $2.57 B).
In their latest fiscal years, Axogen, Inc. reported $225.21M in revenue while Medtronic plc reported $36.36B.
Full pages: Axogen, Inc. and Medtronic plc, or browse the full rankings.